Lowered Risk of Nephrotoxicity through Intervention against the Combined Use of Vancomycin and Tazobactam/Piperacillin: A Retrospective Cohort Study

The combined use of vancomycin (VCM) and tazobactam/piperacillin (TAZ/PIPC) is a major risk factor for nephrotoxicity. We sought to evaluate interventions against the combined use of VCM and TAZ/PIPC. This retrospective cohort study involved patients who considered the combined use of VCM and TAZ/PI...

Descripción completa

Detalles Bibliográficos
Autores principales: Oda, Kazutaka, Hashiguchi, Yumi, Katanoda, Tomomi, Nakata, Hirotomo, Jono, Hirofumi, Saito, Hideyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552786/
https://www.ncbi.nlm.nih.gov/pubmed/34346742
http://dx.doi.org/10.1128/spectrum.00355-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552786/
https://www.ncbi.nlm.nih.gov/pubmed/34346742
http://dx.doi.org/10.1128/spectrum.00355-21

Ejemplares similares